6-EAPB
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
1-(benzofuran-6-yl)-N-ethylpropan-2-amine
|
|
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1632539-47-9 |
| Chemical data | |
| Formula | C13H17NO |
| Molar mass | 239.74 |
|
|
|
6-EAPB (1-(benzofuran-6-yl)-N-ethylpropan-2-amine) is a psychedelic and entactogenic drug of the benzofuran class;[1] it is structurally related to 6-APB and MDMA.
Legality[edit]
As an N-ethyl derivative of 6-APB, 6-EAPB fell outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013.[2] The ACMD has advised that 6-EAPB (and other benzofurans) are moved to Class B,[3] this came into action on 10 June 2014.[4]
See also[edit]
References[edit]
- ^ Taschwer, Magdalena; Hofer, Manfred G.; Schmid, Martin G. (October 2014). "Enantioseparation of benzofurys and other novel psychoactive compounds by CE and sulfobutylether β-cyclodextrin as chiral selector added to the BGE". ELECTROPHORESIS 35 (19): 2793–2799. doi:10.1002/elps.201400164.
- ^ "Temporary class drug order on benzofury and NBOMe compounds". Retrieved 15 June 2015.
- ^ "ACMD recommends permanent ban on two "legal highs"". Retrieved 15 June 2015.
- ^ "Ban on NBOMe and benzofurans comes into force". Retrieved 15 June 2015.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
